Design
Review
Authors
Loading...
Does not warrant changes in antiplatelet regimens; leaves open whether vWF-targeted agents improve outcomes in trials.
Key points are not available for this paper at this time.
Shinya Goto (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: